Cardio Diagnostics Holdings reported revenue of $0.01M and net income of -$1.50M for the quarter ended Jun 2026, down 28.3% year over year. This income statement covers 21 quarters of results from Jun 2021 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | |||||||||||||||||||||
| Revenue | 950.00 | 0.00M | 0.01M | 0.01M | 0.02M | 0.01M | 0.01M | 0.00M | 940.00 | 0.01M | 0.00M | 0.00M | 0.00M | 0.01M | |||||||
| Operating items | |||||||||||||||||||||
| Research & DevelopmentR&D | 0.02M | 0.03M | 0.02M | 0.03M | 0.09M | 0.03M | 0.04M | 0.02M | 0.03M | 0.06M | 0.05M | 1.09M | 0.19M | 0.20M | 0.20M | 0.19M | |||||
| Selling, General & AdministrativeSG&A | 0.21M | 0.75M | 1.13M | 2.32M | 1.56M | 2.51M | 1.38M | 1.49M | 4.12M | 1.29M | 1.42M | 0.04M | 1.28M | 1.30M | 1.71M | -0.01M | 1.46M | 1.14M | |||
| Restructuring CostsRestructuring | 0.06M | 0.06M | |||||||||||||||||||
| Other Operating ExpensesOther Opex | 721.00 | 0.02M | -0.05M | -0.05M | 0.01M | 0.04M | 0.05M | 0.02M | 0.04M | 0.03M | 0.02M | -0.06M | -0.05M | 0.39M | 0.16M | 0.19M | 1.47M | 0.14M | 0.17M | ||
| Operating ExpensesOpex | 721.00 | 0.02M | 0.23M | 0.79M | 1.15M | 2.38M | 1.70M | 2.55M | 1.45M | 1.55M | 4.17M | 1.29M | 1.42M | 1.52M | 1.63M | 1.69M | 1.71M | 1.47M | 1.79M | 1.50M | |
| Operating IncomeOp. Inc | -721.00 | -0.15M | -0.23M | -0.79M | -1.15M | -2.38M | -1.70M | -2.55M | -1.44M | -1.54M | -4.16M | -1.28M | -1.41M | -1.52M | -1.63M | -1.68M | -1.71M | -1.46M | -1.78M | -1.50M | |
| EBIT | -721.00 | -0.15M | -0.23M | -0.79M | -1.15M | -2.38M | -1.70M | -2.55M | -1.44M | -1.54M | -4.16M | -1.28M | -1.41M | -1.52M | -1.63M | -1.68M | -1.71M | -1.46M | -1.78M | -1.50M | |
| Non-operating items | |||||||||||||||||||||
| Non Operating Interest Expenses | 5.02M | 1.05M | 0.57M | 0.10M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | |||||||
| Non Operating Investment IncomeNon-Op. Investment Inc. | 484.00 | 0.00M | 0.01M | 0.37M | |||||||||||||||||
| Other Non Operating IncomeOther Non Op Inc. | -0.06M | -0.06M | 5.69M | -1.47M | -0.49M | -0.20M | -0.01M | -0.01M | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | -0.00M | |||||
| Net income details | |||||||||||||||||||||
| EBT | -721.00 | -0.14M | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Profit After TaxPAT | -721.00 | -0.14M | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Income from Continuing OperationsIncome (Continuing) | -721.00 | -0.14M | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Consolidated Net IncomeConsol Net Inc. | -721.00 | -0.14M | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Income towards Parent CompanyParent Net Inc | -721.00 | -0.14M | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Net Income towards Common StockholdersNet Income | -721.00 | -0.14M | -0.29M | -0.84M | -1.15M | -2.38M | -1.03M | -4.02M | -1.93M | -1.39M | -4.16M | -1.29M | -1.41M | -1.52M | -1.64M | -1.68M | -1.71M | -1.47M | -1.79M | -1.50M | |
| Additional items | |||||||||||||||||||||
| EPS (Basic) | -0.12 | -0.04 | -0.13 | -0.18 | -0.77 | -0.11 | -0.39 | -0.16 | -0.11 | -0.20 | -0.06 | -0.06 | -0.06 | -0.97 | -0.97 | -0.98 | -0.84 | -0.63 | -0.51 | ||
| EPS (Diluted) | -0.12 | -0.07 | -0.16 | -0.17 | -0.77 | -0.11 | -0.39 | -0.16 | -0.11 | -0.20 | -0.06 | -0.06 | -0.06 | -0.97 | -0.97 | -0.98 | -0.84 | -0.63 | -0.51 | ||
| Shares Outstanding | 1.16M | 6.50M | 6.50M | 6.50M | 3.09M | 9.55M | 10.24M | 11.90M | 12.69M | 21.08M | 22.61M | 24.44M | 26.89M | 1.69M | 1.74M | 1.76M | 1.75M | 2.84M | 2.96M | ||
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 1.16M | 4.22M | 5.43M | 6.61M | 3.09M | 9.55M | 10.24M | 11.90M | 12.69M | 21.08M | 22.61M | 24.44M | 26.89M | 1.69M | 1.74M | 1.76M | 1.75M | 2.84M | 2.96M | ||
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 1.16M | 6.50M | 6.50M | 6.50M | 3.09M | 9.62M | 11.18M | 13.12M | 12.69M | 21.08M | 22.61M | 24.44M | 26.89M | 1.74M | 1.74M | 1.77M | 1.83M | 2.96M | 2.96M | ||
| EBITDA | -721.00 | -0.15M | -0.23M | -0.79M | -1.15M | -2.38M | -1.70M | -2.55M | -1.44M | -1.54M | -4.16M | -1.28M | -1.41M | -1.52M | -1.63M | -1.68M | -1.71M | -1.46M | -1.78M | -1.50M | |
| Interest ExpensesInt Expense | 5.02M | 1.05M | 0.57M | 0.10M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |